Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.72 is 197% above its 5-year average of -1.77, near the high end of its 5-year range (-2.70–1.72).
224.97% above its 12-month average of -1.38.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.18.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:57:47.579Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
1.72
EARNINGS PER SHARE (EPS) AVG TTM
-1.38
EARNINGS PER SHARE (EPS) AVG 3Y
-1.54
EARNINGS PER SHARE (EPS) AVG 5Y
-1.77
EARNINGS PER SHARE (EPS) AVG 10Y
-1.81
EARNINGS PER SHARE (EPS) AVG 15Y
-1.85
EARNINGS PER SHARE (EPS) AVG 20Y
-1.83
CURRENT VS TTM AVG
+224.97%
CURRENT VS 3Y AVG
+211.38%
CURRENT VS 5Y AVG
+197.37%
CURRENT VS 10Y AVG
+195.19%
CURRENT VS 15Y AVG
+192.90%
CURRENT VS 20Y AVG
+193.96%
Omeros Corporation
Market Cap
$1.34B
Earnings Per Share (EPS)
1.72
TTM Avg
-1.38
3Y Avg
-1.54
5Y Avg
-1.77
Market Cap
$1.34B
Earnings Per Share (EPS)
N/A
TTM Avg
-2.33
3Y Avg
-2.33
5Y Avg
-2.33
Market Cap
$1.32B
Earnings Per Share (EPS)
-1.04
TTM Avg
-0.49
3Y Avg
-0.48
5Y Avg
-0.41
Market Cap
$1.39B
Earnings Per Share (EPS)
N/A
TTM Avg
-1.26
3Y Avg
-1.26
5Y Avg
-1.26
Market Cap
$1.40B
Earnings Per Share (EPS)
-8.88
TTM Avg
53.77
3Y Avg
24.70
5Y Avg
19.33
Market Cap
$1.41B
Earnings Per Share (EPS)
0.90
TTM Avg
0.79
3Y Avg
0.56
5Y Avg
0.48
Market Cap
$1.42B
Earnings Per Share (EPS)
5.37
TTM Avg
-2.79
3Y Avg
-4.06
5Y Avg
-3.18
Market Cap
$1.44B
Earnings Per Share (EPS)
-2.74
TTM Avg
-3.05
3Y Avg
-2.66
5Y Avg
-2.66
Market Cap
$1.44B
Earnings Per Share (EPS)
-5.84
TTM Avg
-6.06
3Y Avg
-7.62
5Y Avg
-6.71
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Omeros Corporation (OMER) | $1.34B | 1.72 | -1.38 | -1.54 | -1.77 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.34B | N/A | -2.33 | -2.33 | -2.33 |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.32B | -1.04 | -0.49 | -0.48 | -0.41 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.39B | N/A | -1.26 | -1.26 | -1.26 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | -8.88 | 53.77 | 24.70 | 19.33 |
| The Pennant Group, Inc. (PNTG)vs › | $1.41B | 0.90 | 0.79 | 0.56 | 0.48 |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 5.37 | -2.79 | -4.06 | -3.18 |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.44B | -2.74 | -3.05 | -2.66 | -2.66 |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | -5.84 | -6.06 | -7.62 | -6.71 |
| Kardigan, Inc. (KARD)vs › | $1.27B | N/A | -3.20 | -3.20 | -3.20 |
Trailing EPS (TTM)
$1.72
Forward EPS (Est.)
$0.91
P/E Ratio
10.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.05 |
| 2024-12-31 | -2.70 |
| 2023-12-31 | -1.88 |
| 2021-12-31 | -1.79 |
| 2020-12-31 | -2.41 |
| 2018-12-31 | -2.61 |
| 2017-12-31 | -1.17 |
| 2016-12-31 | -1.65 |
| 2015-12-31 | -2.00 |
| 2014-12-31 | -2.22 |
| 2013-12-31 | -1.39 |
| 2012-12-31 | -1.59 |
| 2011-12-31 | -1.29 |
| 2010-12-31 | -1.37 |
| 2009-12-31 | -2.92 |
| 2008-12-31 | -2.22 |
| 2007-12-31 | -1.62 |
| 2006-12-31 | -1.60 |
| 2005-12-31 | -0.52 |
